Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03973281Not ApplicableActive Not Recruiting

EASE: The Materna Prep Pivotal Study

Role: lead

NCT06397885Active Not Recruiting

Prospective on Market Patient-reported Outcomes for Milli

Role: lead

NCT06698185Not ApplicableWithdrawn

A Clinical Phase II Study of the Materna Device to Shorten Delivery Time During Childbirth

Role: lead

NCT06126328Phase 2Completed

Materna Prep Study Phase II

Role: lead

NCT02332759Not ApplicableCompleted

A Pilot Study To Evaluate The Preliminary Safety And Feasibility Of The Materna Medical Device

Role: collaborator

All 5 trials loaded